Man Group PLC Black Diamond Therapeutics, Inc. Transaction History
Man Group PLC
- $37.6 Billion
- Q2 2024
A detailed history of Man Group PLC transactions in Black Diamond Therapeutics, Inc. stock. As of the latest transaction made, Man Group PLC holds 12,416 shares of BDTX stock, worth $40,227. This represents 0.0% of its overall portfolio holdings.
Number of Shares
12,416
Previous 119,460
89.61%
Holding current value
$40,227
Previous $605,000
90.58%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding BDTX
# of Institutions
105Shares Held
46.1MCall Options Held
318KPut Options Held
263K-
T. Rowe Price Investment Management, Inc. Baltimore, MD10.7MShares$34.5 Million0.03% of portfolio
-
Bellevue Group Ag Kuesnacht, V88.52MShares$27.6 Million0.66% of portfolio
-
Nea Management Company, LLC Timonium, MD4.45MShares$14.4 Million1.96% of portfolio
-
Black Rock Inc. New York, NY3.22MShares$10.4 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.32MShares$7.51 Million0.0% of portfolio
About Black Diamond Therapeutics, Inc.
- Ticker BDTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 36,339,500
- Market Cap $118M
- Description
- Black Diamond Therapeutics, Inc., a biotechnology company, discover, develops, and commercializes medicines for patient with genetically defined tumors. It develops BDTX-189, an irreversible small molecule inhibitor that is designed to targets oncogenic proteins defined by the non-canonical epidermal growth factor receptor (EGFR) and human epide...